News · Approval
1,552 stories
Aug 18, 26STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Aug 18, 26Amylyx’s bet on a GLP-1 blocker pays off
Aug 18, 26Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia
Aug 17, 26STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
Aug 17, 26Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win